Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 6/20 | 0.49 |
| ▸ | TGFBR1 | P36897 | 3/20 | 0.49 |
| ▸ | DPP4 | P27487 | 2/20 | 0.46 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.46 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.46 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.46 |
| ▸ | FAP | Q12884 | 1/20 | 0.46 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.43 |
| ▸ | ECE1 | P42892 | 2/20 | 0.41 |
| ▸ | ACE | P12821 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29590449 | 1.00 | MME (0.49) | MMETGFBR1DPP4DPP8DPP9 | |
| SCHEMBL29696989 | 1.00 | MME (0.49) | MMETGFBR1DPP4DPP8DPP9 | |
| SCHEMBL29630533 | 1.00 | MME (0.49) | MMETGFBR1DPP4DPP8DPP9 | |
| SCHEMBL6674368 | 0.96 | TGFBR1 (0.52) | MMETGFBR1DPP4DPP8DPP9 | |
| SCHEMBL28124001 | 0.96 | TGFBR1 (0.52) | MMETGFBR1DPP4DPP8DPP9 | |
| SCHEMBL31630525 | 0.90 | MME (0.55) | MMETGFBR1DPP4DPP8DPP9 | |
| SCHEMBL3289560 | 0.90 | MME (0.55) | MMETGFBR1DPP4DPP8DPP9 | |
| SCHEMBL3289576 | 0.90 | MME (0.55) | MMETGFBR1DPP4DPP8DPP9 | |
| SCHEMBL30930167 | 0.90 | MME (0.51) | MMEDPP4DPP8DPP9DPP7 | |
| SCHEMBL29462928 | 0.90 | DPP4 (0.43) | MMETGFBR1DPP4DPP8DPP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116948034-B | Active type heterophagy antibody blocker Block-5S and preparation method thereof | 南京珀尔泰生物技术有限公司 | 2024-06-25 | — | — | CN | disclosed |
| US-20240141305-A1 | HSD17B13 VARIANTS AND USES THEREOF | REGENERON PHARMACEUTICALS, INC. | 2024-05-02 | — | — | US | disclosed |
| US-11845963-B2 | HSD17B13 variants and uses thereof | REGENERON PHARMACEUTICALS, INC. (US) | 2023-12-19 | — | — | US | disclosed |
| CN-116948034-A | Active type heterophagy antibody blocker Block-5S and preparation method thereof | 南京珀尔泰生物技术有限公司 | 2023-10-27 | — | — | CN | disclosed |
| US-11753628-B2 | HSD17B13 variants and uses thereof | REGENERON PHARMACEUTICALS, INC. (US) | 2023-09-12 | — | — | US | disclosed |
| CN-110003336-B | PD-1 single domain antibody, nucleotide sequence and kit | 深圳普瑞金生物药业股份有限公司 | 2023-05-12 | — | — | CN | disclosed |
| WO-2022272026-A1 | METHODS AND COMPOSITIONS RELATING TO TISSUE-PROTECTIVE ERYTHROPOIETIN | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2022-12-29 | — | — | WO | disclosed |
| US-20220267743-A1 | HSD17B13 Variants And Uses Thereof | REGENERON PHARMACEUTICALS, INC. | 2022-08-25 | — | — | US | disclosed |